Marketing-authorisation holder · United States
ModernaTX, Inc.
8 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| flusiva,mflusiva37.5ug · For Injection | Influenza mrna vaccine | United States | Marketed | 2026 |
| mnexspike10ug · Injection | Covid-19 mrna vaccine | United States | Marketed | 2025 |
| mresvia50ug/.5ml · For Injection | Respiratory syncytial virus vaccines | United States | Marketed | 2024 |
| Spikevax100ug · Injection | Covid-19 mrna vaccine | United States | Not marketed | 2022 |
| Spikevax50ug · Injection | Covid-19 mrna vaccine | United States | Not marketed | 2023 |
| Spikevax50ug · Injection | Covid-19 mrna vaccine | United States | Not marketed | 2023 |
| Spikevax50UG/0.5mL · Injection | Covid-19 mrna vaccine | United States | Marketed | 2023 |
| Spikevax25UG/0.25mL · Injection | Covid-19 mrna vaccine | United States | Marketed | 2025 |